NEYROS
The research company, carrying out studies and development of new pharmaceutical drug candidate for treatment of neurodegenerative disorders and cerebrovascular ischemia.
NEYROS projects are aimed at creating new pharmaceutical candidates for the treatment of Parkinson's disease, age-related dementia, Alzheimer's disease, as well as anti-ischemic drugs for increasing the duration of the "golden hour" during stroke.
Scientists have developed a method that, by acting on brain stem cells, increases the number of neurons, thereby slowing down the aging process of the brain, and partially returning to it the lost cognitive functions
The research group of the Tyumen State University (Tyumen State University) has developed a biomorphic (imitating nature) model of a neuron and formulated conceptual principles for constructing a neural network based on it. The results are published in Neural Computing and Applications.
Scientists at the Vorozhtsov Novosibirsk Institute of Organic Chemistry (NIOC) have selected a substance that restores neurons damaged by Parkinson's disease.
